Bioxytran, Inc. – OTC:BIXT

Bioxytran stock price today

$0.078
-0.01
-16.23%
Financial Health
0
1
2
3
4
5
6
7
8
9

Bioxytran stock price monthly change

+4.49%
month

Bioxytran stock price quarterly change

+4.49%
quarter

Bioxytran stock price yearly change

-41.88%
year

Bioxytran key metrics

Market Cap
 60.27M
Enterprise value
 51.37M
P/E
 -21.5
EV/Sales
 N/A
EV/EBITDA
 -15.75
Price/Sales
 N/A
Price/Book
 -15.03
PEG ratio
 -0.43
EPS
 -0.03
Revenue
 N/A
EBITDA
 -2.78M
Income
 -4.25M
Revenue Q/Q
 -55.91%
Revenue Y/Y
 -113.28%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Bioxytran stock price history

Bioxytran stock forecast

Bioxytran financial statements

Profit Margin

Bioxytran, Inc. (OTC:BIXT): Profit margin
Jun 2023 0 -1.41M
Sep 2023 50.50K -1.00M -1982.4%
Dec 2023 -118.23K -1.04M 885.08%
Mar 2024 29.86K -800.32K -2680.09%
BIXT income statement history

Debt to Assets

Bioxytran, Inc. (OTC:BIXT): Debt to assets
Jun 2023 143061 2.76M 1935.71%
Sep 2023 189043 2.33M 1234.09%
Dec 2023 137638 3.24M 2360.9%
Mar 2024 125540 1.11M 888.88%
BIXT balance sheet history

Cash Flow

Bioxytran, Inc. (OTC:BIXT): Cash Flow
Jun 2023 -153.28K -20.33K 65K
Sep 2023 -342.57K -12.69K 390.36K
Dec 2023 -92.62K -6.56K 45K
Mar 2024 -75.56K -5.99K 65.5K
BIXT cash flow history

Bioxytran alternative data

Bioxytran
Employees

Bioxytran, Inc. (OTC:BIXT): Employee count
Aug 2023 2
Sep 2023 2
Oct 2023 2
Nov 2023 2
Dec 2023 2
Jan 2024 2
Feb 2024 2
Mar 2024 2
Apr 2024 2
May 2024 2
Jun 2024 3
Jul 2024 3

Bioxytran other data

Bioxytran
Insider Trading

Bioxytran, Inc. (OTC:BIXT): Insider trades (number of shares)
Period Buy Sel
Oct 2013 0 100000
Nov 2013 0 54953
Mar 2014 0 100000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
HAIT PAUL W 10 percent owner
 Common Stock 95,225 $0.04 $3,809
Sale
HAIT PAUL W 10 percent owner
 Common Stock 4,775 $0.04 $191
Sale
HAIT PAUL W 10 percent owner
 U.S. Rare Earth Minerals Common Stock 54,953 $0.1 $5,275
Sale
HAI PAUL W 10 percent owner
 U.S. RARE EARTH MINERALS 100,000 $0.1 $10,000
Sale
HAIT PAUL W. 10 percent owner
 Common Stock 34,500 N/A N/A
Sale
CULLISON DENNIS director, 10 percent owner, off..
 Common Stock 200,000 N/A N/A
Sale
HAIT PAUL W. 10 percent owner
 Common Stock 383,000 N/A N/A
Sale
CULLISON DENNIS director, 10 percent owner, off..
 Common Stock 2,000,000 $0 $2,000
Sale
CULLISON DENNIS director, 10 percent owner, off..
 Common Stock 2,000,000 $0 $2,000
Sale
CULLISON DENNIS director, 10 percent owner, off..
 Common Stock 250,000 N/A N/A
BIXT insider trading transactions

Bioxytran
Latest News

Thursday, 19 September 2024
accesswire.com
Thursday, 18 July 2024
globenewswire.com
Thursday, 27 June 2024
globenewswire.com
Wednesday, 6 March 2024
globenewswire.com
Wednesday, 21 February 2024
globenewswire.com
Tuesday, 24 October 2023
globenewswire.com
Wednesday, 4 October 2023
globenewswire.com
Thursday, 14 September 2023
globenewswire.com
Thursday, 24 August 2023
globenewswire.com
Tuesday, 8 August 2023
globenewswire.com
Monday, 31 July 2023
globenewswire.com
Wednesday, 29 March 2023
Proactive Investors

Frequently Asked Questions (FAQ)

  • What's the price of Bioxytran stock today?

    One share of Bioxytran stock can currently be purchased for approximately $0.08.

  • When is Bioxytran's next earnings date?

    Unfortunately, Bioxytran's (BIXT) next earnings date is currently unknown.

  • Does Bioxytran pay dividends?

    No, Bioxytran does not pay dividends.

  • How much money does Bioxytran make?

    Bioxytran has a market capitalization of 60.27M.

  • What is Bioxytran's stock symbol?

    Bioxytran, Inc. is traded on the OTC under the ticker symbol "BIXT".

  • What is Bioxytran's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Bioxytran?

    Shares of Bioxytran can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Bioxytran have?

    As Jul 2024, Bioxytran employs 3 workers, which is 50% more then previous quarter.

  • When Bioxytran went public?

    Bioxytran, Inc. is publicly traded company for more then 15 years since IPO on 5 Jan 2010.

  • What is Bioxytran's official website?

    The official website for Bioxytran is bioxytraninc.com.

  • Where are Bioxytran's headquarters?

    Bioxytran is headquartered at 233 Needham Street, Newton, MA.

  • How can i contact Bioxytran?

    Bioxytran's mailing address is 233 Needham Street, Newton, MA and company can be reached via phone at +61 74541199.

Bioxytran company profile:

Bioxytran, Inc.

bioxytraninc.com
Exchange:

OTC

Full time employees:

2

Industry:

Biotechnology

Sector:

Healthcare

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.

+61 74541199
233 Needham Street
Newton, MA 02464

CIK: 0001445815
ISIN: US09075D1028
CUSIP: 09075D102